Steven Trifilio

2.0k total citations
55 papers, 1.3k citations indexed

About

Steven Trifilio is a scholar working on Oncology, Infectious Diseases and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Steven Trifilio has authored 55 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 17 papers in Infectious Diseases and 13 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Steven Trifilio's work include Neutropenia and Cancer Infections (16 papers), Antifungal resistance and susceptibility (14 papers) and Methemoglobinemia and Tumor Lysis Syndrome (8 papers). Steven Trifilio is often cited by papers focused on Neutropenia and Cancer Infections (16 papers), Antifungal resistance and susceptibility (14 papers) and Methemoglobinemia and Tumor Lysis Syndrome (8 papers). Steven Trifilio collaborates with scholars based in United States, Philippines and Lebanon. Steven Trifilio's co-authors include Jayesh Mehta, Charles L. Bennett, Martin S. Tallman, June M. McKoy, Andrew M. Evens, Judy Pi, Paul R. Yarnold, Marc H. Scheetz, Cara C. Tigue and Ali McBride and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Steven Trifilio

54 papers receiving 1.2k citations

Peers

Steven Trifilio
Donna Salzman United States
Lutz Renders Germany
Steve Trifilio United States
Jan Goßmann Germany
Curt A. Ries United States
Parastoo B. Dahi United States
Donna Salzman United States
Steven Trifilio
Citations per year, relative to Steven Trifilio Steven Trifilio (= 1×) peers Donna Salzman

Countries citing papers authored by Steven Trifilio

Since Specialization
Citations

This map shows the geographic impact of Steven Trifilio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven Trifilio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven Trifilio more than expected).

Fields of papers citing papers by Steven Trifilio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven Trifilio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven Trifilio. The network helps show where Steven Trifilio may publish in the future.

Co-authorship network of co-authors of Steven Trifilio

This figure shows the co-authorship network connecting the top 25 collaborators of Steven Trifilio. A scholar is included among the top collaborators of Steven Trifilio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven Trifilio. Steven Trifilio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mehta, Jayesh, et al.. (2020). Revisiting Infectious Complications Following Total Parenteral Nutrition Use During Hematopoietic Stem Cell Transplantation. Journal of the Advanced Practitioner in Oncology. 11(7). 675–682. 4 indexed citations
3.
Trifilio, Steven & Jayesh Mehta. (2019). Aztreonam and Vancomycin for Initial Treatment of Febrile Neutropenia in Penicillin-Allergic Patients During Hematopoietic Stem Cell Transplantation. Journal of the Advanced Practitioner in Oncology. 10(7). 685–690. 2 indexed citations
4.
McLaughlin, Milena M., et al.. (2017). Ciprofloxacin vs levofloxacin for prophylaxis during hematopoietic stem‐cell transplantation. Clinical Transplantation. 32(1). 6 indexed citations
6.
Raizer, Jeffrey J., Karen Fitzner, Daniel I. Jacobs, et al.. (2015). Economics of Malignant Gliomas: A Critical Review. Journal of Oncology Practice. 11(1). e59–e65. 47 indexed citations
7.
Riches, Marcie, Steven Trifilio, Kwang Woo Ahn, et al.. (2015). Risk factors and impact of non-Aspergillus mold infections following allogeneic HCT: a CIBMTR infection and immune reconstitution analysis. Bone Marrow Transplantation. 51(2). 277–282. 24 indexed citations
8.
Allen, Katherine, Jonathan Cotliar, Steven M. Belknap, et al.. (2015). Risk of Anaphylaxis with Repeated Courses of Rasburicase: A Research on Adverse Drug Events and Reports (RADAR) Project. Drug Safety. 38(2). 183–187. 47 indexed citations
9.
McKoy, June M., Matthew J. Fisher, D. Mark Courtney, et al.. (2013). Results from the First Decade of Research Conducted by the Research on Adverse Drug Events and Reports (RADAR) Project. Drug Safety. 36(5). 335–347. 8 indexed citations
10.
Garg, Vishvas, Dennis W. Raisch, June M. McKoy, et al.. (2013). Impact of United States Food and Drug Administration's boxed warnings on adverse drug reactions reporting rates and risk mitigation for multiple myeloma drugs. Expert Opinion on Drug Safety. 12(3). 299–307. 9 indexed citations
12.
Trifilio, Steven, Zheng Zhou, Jayesh Mehta, et al.. (2013). Idarubicin appears equivalent to dose-intense daunorubicin for remission induction in patients with acute myeloid leukemia. Leukemia Research. 37(8). 868–871. 11 indexed citations
13.
Allen, Katherine, Jonathan Cotliar, Steven M. Belknap, et al.. (2012). Anaphylaxis Associated with Administration of Repeated Courses of Rasburicase: A Research On Adverse Drug Events and Reports (RADAR) Project. Blood. 120(21). 1351–1351. 1 indexed citations
14.
Trifilio, Steven, Alfred Rademaker, Jayesh Mehta, et al.. (2011). Mitoxantrone and etoposide with or without intermediate dose cytarabine for the treatment of primary induction failure or relapsed acute myeloid leukemia. Leukemia Research. 36(4). 394–396. 25 indexed citations
15.
Esterly, John S., et al.. (2010). Evaluation of Hepatotoxicity with Off-Label Oral-Treatment Doses of Voriconazole for Invasive Fungal Infections. Antimicrobial Agents and Chemotherapy. 55(1). 184–189. 13 indexed citations
16.
Trifilio, Steven, Charles L. Bennett, Paul R. Yarnold, et al.. (2007). Breakthrough zygomycosis after voriconazole administration among patients with hematologic malignancies who receive hematopoietic stem-cell transplants or intensive chemotherapy. Bone Marrow Transplantation. 39(7). 425–429. 162 indexed citations
17.
Bennett, Charles L., Andrew M. Evens, Leslie A. Andritsos, et al.. (2006). Haematological malignancies developing in previously healthy individuals who received haematopoietic growth factors: report from the Research on Adverse Drug Events and Reports (RADAR) project. British Journal of Haematology. 135(5). 642–650. 93 indexed citations
18.
Trifilio, Steven, et al.. (2005). Breakthrough zygomycoses in patients receiving antifungal therapy with voriconazole. Journal of Clinical Oncology. 23(16_suppl). 6664–6664. 2 indexed citations
19.
Verma, Amit, Steven Trifilio, Seema Singhal, et al.. (2004). How long after neutrophil recovery should myeloid growth factors be continued in autologous hematopoietic stem cell transplant recipients?. Bone Marrow Transplantation. 33(7). 715–719. 4 indexed citations
20.
Trifilio, Steven, Anita Verma, & Jayesh Mehta. (2004). Antimicrobial prophylaxis in hematopoietic stem cell transplant recipients: heterogeneity of current clinical practice. Bone Marrow Transplantation. 33(7). 735–739. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026